GreggCurtisFonarowMD

Cardiology • Los Angeles, CA

Heart Failure & Transplantation, Preventive Cardiology

Professor of Medicine, UCLA

Join to view full profile

Dr. Fonarow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fonarow's full profile

Already have an account?

Office
UCLA Medical Center
100 Medical Plaza, Suite 630
Los Angeles, CA 90095
Phone+1 310-825-8816

Fax+1 310-825-8816

Summary

Dr. Gregg Fonarow is a cardiologist in Los Angeles, CA and is affiliated with Ronald Reagan UCLA Medical Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 30 years. He specializes in heart failure & transplantation, quality of care, and preventive cardiology and is experienced in general cardiology, preventive cardiology, heart failure, and critical care medicine. He is co-Chief of the UCLA Division of Cardiology.

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1987 - 1990
David Geffen School of Medicine at UCLAClass of 1987

Certifications & Licensure

CA State Medical License 1988 - 2026
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Chairman's Award American Heart Association, 2017
Fellow Heart Failure Society of America Heart Failure Society of America, 2015
Distinguished Clinical Research Award Clinical Research Forum, 2014
Raymond D. Bahr Award of Excellence Society of Chest Pain Centers, 2009
Award of Meritorious Achievement American Heart Association, 2004
W. Proctor Harvey, MD, Young Teacher Award American College of Cardiology, 1998
America's Top Doctors Castle Connolly, 2008-2014
Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting Start of enrollment: 2005 May 01
Completed

Publications & Presentations

PubMed

Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review...
Huzaifa Ul Haq Ansari, Muhammad Ammar Samad, Eman Mahboob, Eeshal Zulfiqar, Shurjeel Uddin Qazi
American Journal of Preventive Cardiology. 2025-03-01
Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry.
Max J Jason, Lucas N Marzec, Jonathan P Piccini, Peter Shrader, Karen S Pieper
International Journal of Cardiology. 2025-02-15
Receipt of respiratory vaccines among patients with heart failure in a multicenter health system registry.
Anna Dermenchyan, Kristen R Choi, Pooya R Bokhoor, David J Cho, Nina Lou A Delavin
Vaccine. 2025-02-06

Journal Articles

Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure—There Is No Time for Delay
Gregg C Fonarow, Clyde W Yancy, JAMA Cardiology
National Trends in Heart Failure Hospitalizations and Readmissions from 2010 to 2017
Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian, JAMA Cardiology
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical Practice
Muthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
Evaluation of Risk-Adjusted Home Time After Hospitalization for Heart Failure as a Potential Hospital Performance Metric
Gregg C Fonarow, Clyde Yancy, JAMA Cardiology
United Network for Organ Sharing 2018 Heart Transplant Reallocation Policy
Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
Door-to-Needle Time and Long-Term Outcomes in Patients with Stroke—Reply
Shumei Man, Gregg C Fonarow, JAMA
Trends in Reperfusion Therapy for in-Hospital Ischemic Stroke in the Endovascular Therapy Era
Feras Akbik, Ying Xian, Eric E Smith, Deepak L Bhatt, Gregg C Fonarow, Lee H Schwamm, JAMA Neurology
Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol–Lowering Therapies Among Medicare Beneficiaries
Gregg C Fonarow, Sandeep R Das, JAMA Cardiology
Cost-Effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure with Reduced Ejection Fraction
Thomas A Gaziano, Gregg C Fonarow, Eugene Braunwald, JAMA Cardiology
Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?
Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic Stroke
Shumei Man, Jeffrey L Saver, Eric E Smith, Deepak L Bhatt, Lee H Schwamm, Gregg C Fonarow, JAMA
Medicare Shared Savings ACOs and Hospice Care for Ischemic Stroke Patients
Lee H Schwamm, Gregg C Fonarow, Journal of the American Geriatrics Society
Coronary the Association of Frailty with in-Hospital Bleeding Among Older Adults with Acute Myocardial Infarction: Insights from the ACTION Registry
Kirk N Garratt, Judith S Hochman, Anita Y Chen, Gregg C Fonarow, Martha Gulati, Karen P Alexander, Matthew T Roe, John A Dodson, Martha J Radford, Sarwat I Chaudhry, ScienceDirect
Patient and Practice Characteristics Associated with Sacubitril/Valsartan Use in the United States
Javed Butler, John A Spertus, Gregg C Fonarow, Journal of Cardiac Failure
Management of Patients with Diabetes and Heart Failure with Reduced Ejection Fraction: An International Comparison
James L Januzzi, Mikhail Kosiborod, Frederick A Masoudi, Darren K McGuire, Suzanne V Arnold, Gregg C Fonarow, Diabetes, Obesity and Metabolism
Clinical Investigations High-Sensitivity C-reactive Protein Elevation in Patients with Prior Myocardial Infarction in the United States
Gregg Fonarow, MD, ScienceDirect
Clinical Research Vaccination Trends in Patients with Heart Failure: Insights from Get with the Guidelines–Heart Failure
Adam D DeVore, Adrian F Hernandez, Scott D Solomon, Orly Vardeny, Ankeet S Bhatt, Gregg C Fonarow, Robert J Mentz, Clyde W Yancy, Ileana L Pina, ScienceDirect
Diabetes Is Associated with Worse in-Hospital and 30-Day Post-Discharge Morbidity in Patients with Heart Failure with Preserved Ejection Fraction: Findings from the Ge...
Gregg C Fonarow, Paul A Heidenreich, Clyde W Yancy, Natasha Altman, Journal of Cardiac Failure
Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart Failure
Kevin S Shah, Boback Ziaeian, Freny V Mody, Ali Nsair, Gregg C Fonarow, Journal of Cardiac Failure
Participation in Get with the Guidelines–Stroke and Its Association with Quality of Care for Stroke
Dawn O Kleindorfer, Brett M Kissela, Gregg C Fonarow, Virginia J Howard, Lee H Schwamm, Adam Jasne, JAMA
Incremental Prognostic Value of Renal Function for Stroke Prediction in Atrial Fibrillation☆
Gregg C Fonarow, Kenneth W Mahaffey, Sean D Pokorney, Eric D Peterson, Jonathan P Piccini, International Journal of Cardiology
Original Investigation Medical Therapy for Heart Failure with Reduced Ejection Fraction: The CHAMP-HF Registry
John A Spertus, Javed Butler, Nancy M Albert, Adam D DeVore, Gregg C Fonarow, Laine Thomas, Adrian F Hernandez, ScienceDirect
Point/Counterpoint the Hospital Readmissions Reduction Program: Evidence for Harm
Gregg Fonarow, MD, ScienceDirect
Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients with Acute Ischemic Stroke in China
Gregg C Fonarow, Eric D Peterson, Lee H Schwamm, JAMA
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients with Heart Failure
Adrian F. Hernandez, Greg C. Fonarow, Nancy M. Albert, Laine Thomas, John A. Spertus, Adam D. DeVore, Javed Butler, JACC: Cardiovascular Imaging
Join now to see all

Lectures

Hospital Re-Admission Measure Is the Right Quality Measure in Heart Failure
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

VERTIS CV Trial: Heterogeneity in Clinical Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Type II Diabetes?September 2020
Cost-Effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure with Reduced Ejection FractionAugust 2020
Cost-Effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure with Reduced Ejection FractionAugust 2020
Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?July 2020
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic StrokeJune 2020
Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection FractionDecember 2017
2017 AHA/ACC Clinical Performance and Quality Measures for Adults with ST-Elevation and Non–ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresOctober 2017
Join now to see all

Press Mentions

CVD Polypill a High Value, Cost Savings Treatment in Underserved PopulationJanuary 21st, 2025
Finerenone Increases Hyperkalemia Risk in Patients with Mild Heart FailureJanuary 17th, 2025
Education, Feedback Boosts Pharmacists’ HF Medication RatesNovember 17th, 2024
Join now to see all